APO Research
Talk to an analyst

APO RESEARCH · REPORT

CGT Drugs

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global CGT Drugs Market Analysis and Forecast 2026-2032

30 December 2025198 pages

Choose your research edition.

Industry ResearchCGT Drugs Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal CGT Drugs Industry Growth and Trends Forecast to 2032108 pages · $3,450 USDMarket StructureGlobal CGT Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal CGT Drugs Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal CGT Drugs Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global CGT Drugs market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for CGT Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for CGT Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for CGT Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for CGT Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of CGT Drugs include Bluebird Bio, Celgene Corporation, Juno Therapeutics, Kite Pharma, Orchard Therapeutics, Spark Therapeutics, Amgen, Fosun Kite Biotechnology and GSK, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for CGT Drugs, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of CGT Drugs, also provides the sales of main regions and countries. Of the upcoming market potential for CGT Drugs, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the CGT Drugs sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global CGT Drugs market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for CGT Drugs sales, projected growth trends, production technology, application and end-user industry.

CGT Drugs Segment by Company

Bluebird Bio

Celgene Corporation

Juno Therapeutics

Kite Pharma

Orchard Therapeutics

Spark Therapeutics

Amgen

Fosun Kite Biotechnology

GSK

Novartis

SiBiono

Sunway Biotech

Janssen Biotech

Sequoia

CGT Drugs Segment by Type

CAR-T Therapy

Viral Vector Therapy

Stem Cell Therapy

Oncolytic Virus Therapy

CGT Drugs Segment by Application

Tumor Disease

Eye Disease

Rare Disease

Others

CGT Drugs Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global CGT Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of CGT Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of CGT Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of CGT Drugs in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of CGT Drugs manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, CGT Drugs sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global CGT Drugs Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. CAR-T Therapy Major Manufacturers Table 3. Viral Vector Therapy Major Manufacturers Table 4. Stem Cell Therapy Major Manufacturers Table 5. Oncolytic Virus Therapy Major Manufacturers Table 6. Global CGT Drugs Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 7. Tumor Disease Major Manufacturers Table 8. Eye Disease Major Manufacturers Table 9. Rare Disease Major Manufacturers Table 10. Others Major Manufacturers Table 11. CGT Drugs Industry Trends Table 12. CGT Drugs Industry Drivers Table 13. CGT Drugs Industry Opportunities and Challenges Table 14. CGT Drugs Industry Restraints Table 15. Global CGT Drugs Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 16. Global CGT Drugs Revenue by Region (2021-2026) & (US$ Million) Table 17. Global CGT Drugs Revenue by Region (2027-2032) & (US$ Million) Table 18. Global CGT Drugs Revenue Market Share by Region (2021-2026) Table 19. Global CGT Drugs Revenue Market Share by Region (2027-2032) Table 20. Global CGT Drugs Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (Tons) Table 21. Global CGT Drugs Sales by Region (2021-2026) & (Tons) Table 22. Global CGT Drugs Sales by Region (2027-2032) & (Tons) Table 23. Global CGT Drugs Sales Market Share by Region (2021-2026) Table 24. Global CGT Drugs Sales Market Share by Region (2027-2032) Table 25. Global CGT Drugs Revenue by Manufacturers (US$ Million) & (2021-2026) Table 26. Global CGT Drugs Revenue Market Share by Manufacturers (2021-2026) Table 27. Global CGT Drugs Sales by Manufacturers (US$ Million) & (2021-2026) Table 28. Global CGT Drugs Sales Market Share by Manufacturers (2021-2026) Table 29. Global CGT Drugs Sales Price (US$/Ton) of Manufacturers (2021-2026) Table 30. Global CGT Drugs Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 31. Global CGT Drugs Key Manufacturers Manufacturing Sites & Headquarters Table 32. Global CGT Drugs Manufacturers, Product Type & Application Table 33. Global CGT Drugs Manufacturers' Establishment Date Table 34. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 35. Global CGT Drugs by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 36. Global CGT Drugs Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global CGT Drugs Revenue by Type (2021-2026) & (US$ Million) Table 38. Global CGT Drugs Revenue by Type (2027-2032) & (US$ Million) Table 39. Global CGT Drugs Revenue Market Share by Type (2021-2026) Table 40. Global CGT Drugs Revenue Market Share by Type (2027-2032) Table 41. Global CGT Drugs Sales by Type 2021 VS 2025 VS 2032 (Tons) Table 42. Global CGT Drugs Sales by Type (2021-2026) & (Tons) Table 43. Global CGT Drugs Sales by Type (2027-2032) & (Tons) Table 44. Global CGT Drugs Sales Market Share by Type (2021-2026) Table 45. Global CGT Drugs Sales Market Share by Type (2027-2032) Table 46. Global CGT Drugs Price by Type (2021-2026) & (US$/Ton) Table 47. Global CGT Drugs Price by Type (2027-2032) & (US$/Ton) Table 48. Global CGT Drugs Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global CGT Drugs Revenue by Application (2021-2026) & (US$ Million) Table 50. Global CGT Drugs Revenue by Application (2027-2032) & (US$ Million) Table 51. Global CGT Drugs Revenue Market Share by Application (2021-2026) Table 52. Global CGT Drugs Revenue Market Share by Application (2027-2032) Table 53. Global CGT Drugs Sales by Application 2021 VS 2025 VS 2032 (Tons) Table 54. Global CGT Drugs Sales by Application (2021-2026) & (Tons) Table 55. Global CGT Drugs Sales by Application (2027-2032) & (Tons) Table 56. Global CGT Drugs Sales Market Share by Application (2021-2026) Table 57. Global CGT Drugs Sales Market Share by Application (2027-2032) Table 58. Global CGT Drugs Price by Application (2021-2026) & (US$/Ton) Table 59. Global CGT Drugs Price by Application (2027-2032) & (US$/Ton) Table 60. Bluebird Bio Company Information Table 61. Bluebird Bio Business Overview Table 62. Bluebird Bio CGT Drugs Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 63. Bluebird Bio CGT Drugs Product Portfolio Table 64. Bluebird Bio Recent Development Table 65. Celgene Corporation Company Information Table 66. Celgene Corporation Business Overview Table 67. Celgene Corporation CGT Drugs Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 68. Celgene Corporation CGT Drugs Product Portfolio Table 69. Celgene Corporation Recent Development Table 70. Juno Therapeutics Company Information Table 71. Juno Therapeutics Business Overview Table 72. Juno Therapeutics CGT Drugs Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 73. Juno Therapeutics CGT Drugs Product Portfolio Table 74. Juno Therapeutics Recent Development Table 75. Kite Pharma Company Information Table 76. Kite Pharma Business Overview Table 77. Kite Pharma CGT Drugs Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 78. Kite Pharma CGT Drugs Product Portfolio Table 79. Kite Pharma Recent Development Table 80. Orchard Therapeutics Company Information Table 81. Orchard Therapeutics Business Overview Table 82. Orchard Therapeutics CGT Drugs Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 83. Orchard Therapeutics CGT Drugs Product Portfolio Table 84. Orchard Therapeutics Recent Development Table 85. Spark Therapeutics Company Information Table 86. Spark Therapeutics Business Overview Table 87. Spark Therapeutics CGT Drugs Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 88. Spark Therapeutics CGT Drugs Product Portfolio Table 89. Spark Therapeutics Recent Development Table 90. Amgen Company Information Table 91. Amgen Business Overview Table 92. Amgen CGT Drugs Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 93. Amgen CGT Drugs Product Portfolio Table 94. Amgen Recent Development Table 95. Fosun Kite Biotechnology Company Information Table 96. Fosun Kite Biotechnology Business Overview Table 97. Fosun Kite Biotechnology CGT Drugs Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 98. Fosun Kite Biotechnology CGT Drugs Product Portfolio Table 99. Fosun Kite Biotechnology Recent Development Table 100. GSK Company Information Table 101. GSK Business Overview Table 102. GSK CGT Drugs Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 103. GSK CGT Drugs Product Portfolio Table 104. GSK Recent Development Table 105. Novartis Company Information Table 106. Novartis Business Overview Table 107. Novartis CGT Drugs Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 108. Novartis CGT Drugs Product Portfolio Table 109. Novartis Recent Development Table 110. SiBiono Company Information Table 111. SiBiono Business Overview Table 112. SiBiono CGT Drugs Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 113. SiBiono CGT Drugs Product Portfolio Table 114. SiBiono Recent Development Table 115. Sunway Biotech Company Information Table 116. Sunway Biotech Business Overview Table 117. Sunway Biotech CGT Drugs Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 118. Sunway Biotech CGT Drugs Product Portfolio Table 119. Sunway Biotech Recent Development Table 120. Janssen Biotech Company Information Table 121. Janssen Biotech Business Overview Table 122. Janssen Biotech CGT Drugs Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 123. Janssen Biotech CGT Drugs Product Portfolio Table 124. Janssen Biotech Recent Development Table 125. Sequoia Company Information Table 126. Sequoia Business Overview Table 127. Sequoia CGT Drugs Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 128. Sequoia CGT Drugs Product Portfolio Table 129. Sequoia Recent Development Table 130. North America CGT Drugs Revenue by Type (2021-2026) & (US$ Million) Table 131. North America CGT Drugs Revenue by Type (2027-2032) & (US$ Million) Table 132. North America CGT Drugs Sales by Type (2021-2026) & (Tons) Table 133. North America CGT Drugs Sales by Type (2027-2032) & (Tons) Table 134. North America CGT Drugs Sales Price by Type (2021-2026) & (US$/Ton) Table 135. North America CGT Drugs Sales Price by Type (2027-2032) & (US$/Ton) Table 136. North America CGT Drugs Revenue by Application (2021-2026) & (US$ Million) Table 137. North America CGT Drugs Revenue by Application (2027-2032) & (US$ Million) Table 138. North America CGT Drugs Sales by Application (2021-2026) & (Tons) Table 139. North America CGT Drugs Sales by Application (2027-2032) & (Tons) Table 140. North America CGT Drugs Sales Price by Application (2021-2026) & (US$/Ton) Table 141. North America CGT Drugs Sales Price by Application (2027-2032) & (US$/Ton) Table 142. North America CGT Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 143. North America CGT Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 144. North America CGT Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 145. North America CGT Drugs Sales by Country (2021 VS 2025 VS 2032) & (Tons) Table 146. North America CGT Drugs Sales by Country (2021-2026) & (Tons) Table 147. North America CGT Drugs Sales by Country (2027-2032) & (Tons) Table 148. North America CGT Drugs Sales Price by Country (2021-2026) & (US$/Ton) Table 149. North America CGT Drugs Sales Price by Country (2027-2032) & (US$/Ton) Table 150. United States CGT Drugs Revenue (2021-2032) & (US$ Million) Table 151. Canada CGT Drugs Revenue (2021-2032) & (US$ Million) Table 152. Europe CGT Drugs Revenue by Type (2021-2026) & (US$ Million) Table 153. Europe CGT Drugs Revenue by Type (2027-2032) & (US$ Million) Table 154. Europe CGT Drugs Sales by Type (2021-2026) & (Tons) Table 155. Europe CGT Drugs Sales by Type (2027-2032) & (Tons) Table 156. Europe CGT Drugs Sales Price by Type (2021-2026) & (US$/Ton) Table 157. Europe CGT Drugs Sales Price by Type (2027-2032) & (US$/Ton) Table 158. Europe CGT Drugs Revenue by Application (2021-2026) & (US$ Million) Table 159. Europe CGT Drugs Revenue by Application (2027-2032) & (US$ Million) Table 160. Europe CGT Drugs Sales by Application (2021-2026) & (Tons) Table 161. Europe CGT Drugs Sales by Application (2027-2032) & (Tons) Table 162. Europe CGT Drugs Sales Price by Application (2021-2026) & (US$/Ton) Table 163. Europe CGT Drugs Sales Price by Application (2027-2032) & (US$/Ton) Table 164. Europe CGT Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 165. Europe CGT Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 166. Europe CGT Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 167. Europe CGT Drugs Sales by Country (2021 VS 2025 VS 2032) & (Tons) Table 168. Europe CGT Drugs Sales by Country (2021-2026) & (Tons) Table 169. Europe CGT Drugs Sales by Country (2027-2032) & (Tons) Table 170. Europe CGT Drugs Sales Price by Country (2021-2026) & (US$/Ton) Table 171. Europe CGT Drugs Sales Price by Country (2027-2032) & (US$/Ton) Table 172. Germany CGT Drugs Revenue (2021-2032) & (US$ Million) Table 173. France CGT Drugs Revenue (2021-2032) & (US$ Million) Table 174. U.K. CGT Drugs Revenue (2021-2032) & (US$ Million) Table 175. Italy CGT Drugs Revenue (2021-2032) & (US$ Million) Table 176. Netherlands CGT Drugs Revenue (2021-2032) & (US$ Million) Table 177. China CGT Drugs Revenue by Type (2021-2026) & (US$ Million) Table 178. China CGT Drugs Revenue by Type (2027-2032) & (US$ Million) Table 179. China CGT Drugs Sales by Type (2021-2026) & (Tons) Table 180. China CGT Drugs Sales by Type (2027-2032) & (Tons) Table 181. China CGT Drugs Sales Price by Type (2021-2026) & (US$/Ton) Table 182. China CGT Drugs Sales Price by Type (2027-2032) & (US$/Ton) Table 183. China CGT Drugs Revenue by Application (2021-2026) & (US$ Million) Table 184. China CGT Drugs Revenue by Application (2027-2032) & (US$ Million) Table 185. China CGT Drugs Sales by Application (2021-2026) & (Tons) Table 186. China CGT Drugs Sales by Application (2027-2032) & (Tons) Table 187. China CGT Drugs Sales Price by Application (2021-2026) & (US$/Ton) Table 188. China CGT Drugs Sales Price by Application (2027-2032) & (US$/Ton) Table 189. Asia CGT Drugs Revenue by Type (2021-2026) & (US$ Million) Table 190. Asia CGT Drugs Revenue by Type (2027-2032) & (US$ Million) Table 191. Asia CGT Drugs Sales by Type (2021-2026) & (Tons) Table 192. Asia CGT Drugs Sales by Type (2027-2032) & (Tons) Table 193. Asia CGT Drugs Sales Price by Type (2021-2026) & (US$/Ton) Table 194. Asia CGT Drugs Sales Price by Type (2027-2032) & (US$/Ton) Table 195. Asia CGT Drugs Revenue by Application (2021-2026) & (US$ Million) Table 196. Asia CGT Drugs Revenue by Application (2027-2032) & (US$ Million) Table 197. Asia CGT Drugs Sales by Application (2021-2026) & (Tons) Table 198. Asia CGT Drugs Sales by Application (2027-2032) & (Tons) Table 199. Asia CGT Drugs Sales Price by Application (2021-2026) & (US$/Ton) Table 200. Asia CGT Drugs Sales Price by Application (2027-2032) & (US$/Ton) Table 201. Asia CGT Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 202. Asia CGT Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 203. Asia CGT Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 204. Asia CGT Drugs Sales by Country (2021 VS 2025 VS 2032) & (Tons) Table 205. Asia CGT Drugs Sales by Country (2021-2026) & (Tons) Table 206. Asia CGT Drugs Sales by Country (2027-2032) & (Tons) Table 207. Asia CGT Drugs Sales Price by Country (2021-2026) & (US$/Ton) Table 208. Asia CGT Drugs Sales Price by Country (2027-2032) & (US$/Ton) Table 209. Japan CGT Drugs Revenue (2021-2032) & (US$ Million) Table 210. South Korea CGT Drugs Revenue (2021-2032) & (US$ Million) Table 211. India CGT Drugs Revenue (2021-2032) & (US$ Million) Table 212. Australia CGT Drugs Revenue (2021-2032) & (US$ Million) Table 213. China Taiwan CGT Drugs Revenue (2021-2032) & (US$ Million) Table 214. Southeast Asia CGT Drugs Revenue (2021-2032) & (US$ Million) Table 215. SAMEA CGT Drugs Revenue by Type (2021-2026) & (US$ Million) Table 216. SAMEA CGT Drugs Revenue by Type (2027-2032) & (US$ Million) Table 217. SAMEA CGT Drugs Sales by Type (2021-2026) & (Tons) Table 218. SAMEA CGT Drugs Sales by Type (2027-2032) & (Tons) Table 219. SAMEA CGT Drugs Sales Price by Type (2021-2026) & (US$/Ton) Table 220. SAMEA CGT Drugs Sales Price by Type (2027-2032) & (US$/Ton) Table 221. SAMEA CGT Drugs Revenue by Application (2021-2026) & (US$ Million) Table 222. SAMEA CGT Drugs Revenue by Application (2027-2032) & (US$ Million) Table 223. SAMEA CGT Drugs Sales by Application (2021-2026) & (Tons) Table 224. SAMEA CGT Drugs Sales by Application (2027-2032) & (Tons) Table 225. SAMEA CGT Drugs Sales Price by Application (2021-2026) & (US$/Ton) Table 226. SAMEA CGT Drugs Sales Price by Application (2027-2032) & (US$/Ton) Table 227. SAMEA CGT Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 228. SAMEA CGT Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 229. SAMEA CGT Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 230. SAMEA CGT Drugs Sales by Country (2021 VS 2025 VS 2032) & (Tons) Table 231. SAMEA CGT Drugs Sales by Country (2021-2026) & (Tons) Table 232. SAMEA CGT Drugs Sales by Country (2027-2032) & (Tons) Table 233. SAMEA CGT Drugs Sales Price by Country (2021-2026) & (US$/Ton) Table 234. SAMEA CGT Drugs Sales Price by Country (2027-2032) & (US$/Ton) Table 235. Brazil CGT Drugs Revenue (2021-2032) & (US$ Million) Table 236. Argentina CGT Drugs Revenue (2021-2032) & (US$ Million) Table 237. Chile CGT Drugs Revenue (2021-2032) & (US$ Million) Table 238. Colombia CGT Drugs Revenue (2021-2032) & (US$ Million) Table 239. Peru CGT Drugs Revenue (2021-2032) & (US$ Million) Table 240. Saudi Arabia CGT Drugs Revenue (2021-2032) & (US$ Million) Table 241. Israel CGT Drugs Revenue (2021-2032) & (US$ Million) Table 242. UAE CGT Drugs Revenue (2021-2032) & (US$ Million) Table 243. Turkey CGT Drugs Revenue (2021-2032) & (US$ Million) Table 244. Iran CGT Drugs Revenue (2021-2032) & (US$ Million) Table 245. Egypt CGT Drugs Revenue (2021-2032) & (US$ Million) Table 246. Key Raw Materials Table 247. Raw Materials Key Suppliers Table 248. CGT Drugs Distributors List Table 249. CGT Drugs Customers List Table 250. Research Programs/Design for This Report Table 251. Authors List of This Report Table 252. Secondary Sources Table 253. Primary Sources List of Figures Figure 1. CGT Drugs Image Figure 2. Global CGT Drugs Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global CGT Drugs Market Size Share 2021 VS 2025 VS 2032 Figure 4. CAR-T Therapy Image Figure 5. Viral Vector Therapy Image Figure 6. Stem Cell Therapy Image Figure 7. Oncolytic Virus Therapy Image Figure 8. Global CGT Drugs Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 9. Global CGT Drugs Market Size Share 2021 VS 2025 VS 2032 Figure 10. Tumor Disease Image Figure 11. Eye Disease Image Figure 12. Rare Disease Image Figure 13. Others Image Figure 14. Global CGT Drugs Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 15. Global CGT Drugs Revenue (2021-2032) & (US$ Million) Figure 16. Global CGT Drugs Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 17. Global CGT Drugs Revenue Market Share by Region: 2025 Versus 2032 Figure 18. Global CGT Drugs Revenue Market Share by Region (2021-2032) Figure 19. Global CGT Drugs Sales (2021-2032) & (Tons) Figure 20. Global CGT Drugs Sales by Region: 2021 VS 2025 VS 2032 (Tons) Figure 21. Global CGT Drugs Sales Market Share by Region (2021-2032) Figure 22. US & Canada & Mexico CGT Drugs Sales YoY (2021-2032) & (Tons) Figure 23. Europe CGT Drugs Sales YoY (2021-2032) & (Tons) Figure 24. China CGT Drugs Sales YoY (2021-2032) & (Tons) Figure 25. Asia (Excluding China) CGT Drugs Sales YoY (2021-2032) & (Tons) Figure 26. South America, Middle East and Africa CGT Drugs Sales YoY (2021-2032) & (Tons) Figure 27. Global CGT Drugs Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 28. Global CGT Drugs Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 29. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 30. Global CGT Drugs Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 31. Global CGT Drugs Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global CGT Drugs Revenue Market Share by Type (2021-2032) Figure 33. Global CGT Drugs Sales by Type (2021 VS 2025 VS 2032) & (Tons) Figure 34. Global CGT Drugs Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 35. Global CGT Drugs Sales Market Share by Type (2021-2032) Figure 36. Global CGT Drugs Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 37. Global CGT Drugs Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global CGT Drugs Revenue Market Share by Application (2021-2032) Figure 39. Global CGT Drugs Sales by Application (2021 VS 2025 VS 2032) & (Tons) Figure 40. Global CGT Drugs Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 41. Global CGT Drugs Sales Market Share by Application (2021-2032) Figure 42. North America CGT Drugs Revenue Share by Type (2021-2032) Figure 43. North America CGT Drugs Sales Share by Type (2021-2032) Figure 44. North America CGT Drugs Revenue Share by Application (2021-2032) Figure 45. North America CGT Drugs Sales Share by Application (2021-2032) Figure 46. North America CGT Drugs Revenue Share by Country (2021-2032) Figure 47. North America CGT Drugs Sales Share by Country (2021-2032) Figure 48. Europe CGT Drugs Revenue Share by Type (2021-2032) Figure 49. Europe CGT Drugs Sales Share by Type (2021-2032) Figure 50. Europe CGT Drugs Revenue Share by Application (2021-2032) Figure 51. Europe CGT Drugs Sales Share by Application (2021-2032) Figure 52. Europe CGT Drugs Revenue Share by Country (2021-2032) Figure 53. Europe CGT Drugs Sales Share by Country (2021-2032) Figure 54. China CGT Drugs Revenue Share by Type (2021-2032) Figure 55. China CGT Drugs Sales Share by Type (2021-2032) Figure 56. China CGT Drugs Revenue Share by Application (2021-2032) Figure 57. China CGT Drugs Sales Share by Application (2021-2032) Figure 58. Asia CGT Drugs Revenue Share by Type (2021-2032) Figure 59. Asia CGT Drugs Sales Share by Type (2021-2032) Figure 60. Asia CGT Drugs Revenue Share by Application (2021-2032) Figure 61. Asia CGT Drugs Sales Share by Application (2021-2032) Figure 62. Asia CGT Drugs Revenue Share by Country (2021-2032) Figure 63. Asia CGT Drugs Sales Share by Country (2021-2032) Figure 64. SAMEA CGT Drugs Revenue Share by Type (2021-2032) Figure 65. SAMEA CGT Drugs Sales Share by Type (2021-2032) Figure 66. SAMEA CGT Drugs Revenue Share by Application (2021-2032) Figure 67. SAMEA CGT Drugs Sales Share by Application (2021-2032) Figure 68. SAMEA CGT Drugs Revenue Share by Country (2021-2032) Figure 69. SAMEA CGT Drugs Sales Share by Country (2021-2032) Figure 70. CGT Drugs Value Chain Figure 71. Manufacturing Cost Structure Figure 72. CGT Drugs Production Mode & Process Figure 73. Direct Comparison with Distribution Share Figure 74. Distributors Profiles Figure 75. Years Considered Figure 76. Research Process Figure 77. Key Executives Interviewed

Scope & coverage.

Types
  • CAR-T Therapy
  • Viral Vector Therapy
  • Stem Cell Therapy
  • Oncolytic Virus Therapy
Applications
  • Tumor Disease
  • Eye Disease
  • Rare Disease
  • Others
Companies covered
  • Bluebird Bio
  • Celgene Corporation
  • Juno Therapeutics
  • Kite Pharma
  • Orchard Therapeutics
  • Spark Therapeutics
  • Amgen
  • Fosun Kite Biotechnology
  • GSK
  • Novartis
  • SiBiono
  • Sunway Biotech
  • Janssen Biotech
  • Sequoia

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 CGT Drugs Market by Type
  3. 1.2.1 Global CGT Drugs Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 CAR-T Therapy
  5. 1.2.3 Viral Vector Therapy
  6. 1.2.4 Stem Cell Therapy
  7. 1.2.5 Oncolytic Virus Therapy
  8. 1.3 CGT Drugs Market by Application
  9. 1.3.1 Global CGT Drugs Market Size by Application, 2021 VS 2025 VS 2032
  10. 1.3.2 Tumor Disease
  11. 1.3.3 Eye Disease
  12. 1.3.4 Rare Disease
  13. 1.3.5 Others
  14. 1.4 Assumptions and Limitations
  15. 1.5 Study Goals and Objectives
2 CGT Drugs Market Dynamics
  1. 2.1 CGT Drugs Industry Trends
  2. 2.2 CGT Drugs Industry Drivers
  3. 2.3 CGT Drugs Industry Opportunities and Challenges
  4. 2.4 CGT Drugs Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global CGT Drugs Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global CGT Drugs Revenue by Region
  3. 3.2.1 Global CGT Drugs Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global CGT Drugs Revenue by Region (2021-2026)
  5. 3.2.3 Global CGT Drugs Revenue by Region (2027-2032)
  6. 3.2.4 Global CGT Drugs Revenue Market Share by Region (2021-2032)
  7. 3.3 Global CGT Drugs Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global CGT Drugs Sales by Region
  9. 3.4.1 Global CGT Drugs Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global CGT Drugs Sales by Region (2021-2026)
  11. 3.4.3 Global CGT Drugs Sales by Region (2027-2032)
  12. 3.4.4 Global CGT Drugs Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global CGT Drugs Revenue by Manufacturers
  2. 4.1.1 Global CGT Drugs Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global CGT Drugs Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global CGT Drugs Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global CGT Drugs Sales by Manufacturers
  6. 4.2.1 Global CGT Drugs Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global CGT Drugs Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global CGT Drugs Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global CGT Drugs Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global CGT Drugs Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global CGT Drugs Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global CGT Drugs Manufacturers, Product Type & Application
  13. 4.7 Global CGT Drugs Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global CGT Drugs Market CR5 and HHI
  16. 4.8.2 2025 CGT Drugs Tier 1, Tier 2, and Tier 3
5 CGT Drugs Market by Type
  1. 5.1 Global CGT Drugs Revenue by Type
  2. 5.1.1 Global CGT Drugs Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global CGT Drugs Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global CGT Drugs Revenue Market Share by Type (2021-2032)
  5. 5.2 Global CGT Drugs Sales by Type
  6. 5.2.1 Global CGT Drugs Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global CGT Drugs Sales by Type (2021-2032) & (Tons)
  8. 5.2.3 Global CGT Drugs Sales Market Share by Type (2021-2032)
  9. 5.3 Global CGT Drugs Price by Type
6 CGT Drugs Market by Application
  1. 6.1 Global CGT Drugs Revenue by Application
  2. 6.1.1 Global CGT Drugs Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global CGT Drugs Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global CGT Drugs Revenue Market Share by Application (2021-2032)
  5. 6.2 Global CGT Drugs Sales by Application
  6. 6.2.1 Global CGT Drugs Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global CGT Drugs Sales by Application (2021-2032) & (Tons)
  8. 6.2.3 Global CGT Drugs Sales Market Share by Application (2021-2032)
  9. 6.3 Global CGT Drugs Price by Application
7 Company Profiles
  1. 7.1 Bluebird Bio
  2. 7.1.1 Bluebird Bio Company Information
  3. 7.1.2 Bluebird Bio Business Overview
  4. 7.1.3 Bluebird Bio CGT Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Bluebird Bio CGT Drugs Product Portfolio
  6. 7.1.5 Bluebird Bio Recent Developments
  7. 7.2 Celgene Corporation
  8. 7.2.1 Celgene Corporation Company Information
  9. 7.2.2 Celgene Corporation Business Overview
  10. 7.2.3 Celgene Corporation CGT Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Celgene Corporation CGT Drugs Product Portfolio
  12. 7.2.5 Celgene Corporation Recent Developments
  13. 7.3 Juno Therapeutics
  14. 7.3.1 Juno Therapeutics Company Information
  15. 7.3.2 Juno Therapeutics Business Overview
  16. 7.3.3 Juno Therapeutics CGT Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Juno Therapeutics CGT Drugs Product Portfolio
  18. 7.3.5 Juno Therapeutics Recent Developments
  19. 7.4 Kite Pharma
  20. 7.4.1 Kite Pharma Company Information
  21. 7.4.2 Kite Pharma Business Overview
  22. 7.4.3 Kite Pharma CGT Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Kite Pharma CGT Drugs Product Portfolio
  24. 7.4.5 Kite Pharma Recent Developments
  25. 7.5 Orchard Therapeutics
  26. 7.5.1 Orchard Therapeutics Company Information
  27. 7.5.2 Orchard Therapeutics Business Overview
  28. 7.5.3 Orchard Therapeutics CGT Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Orchard Therapeutics CGT Drugs Product Portfolio
  30. 7.5.5 Orchard Therapeutics Recent Developments
  31. 7.6 Spark Therapeutics
  32. 7.6.1 Spark Therapeutics Company Information
  33. 7.6.2 Spark Therapeutics Business Overview
  34. 7.6.3 Spark Therapeutics CGT Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Spark Therapeutics CGT Drugs Product Portfolio
  36. 7.6.5 Spark Therapeutics Recent Developments
  37. 7.7 Amgen
  38. 7.7.1 Amgen Company Information
  39. 7.7.2 Amgen Business Overview
  40. 7.7.3 Amgen CGT Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Amgen CGT Drugs Product Portfolio
  42. 7.7.5 Amgen Recent Developments
  43. 7.8 Fosun Kite Biotechnology
  44. 7.8.1 Fosun Kite Biotechnology Company Information
  45. 7.8.2 Fosun Kite Biotechnology Business Overview
  46. 7.8.3 Fosun Kite Biotechnology CGT Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Fosun Kite Biotechnology CGT Drugs Product Portfolio
  48. 7.8.5 Fosun Kite Biotechnology Recent Developments
  49. 7.9 GSK
  50. 7.9.1 GSK Company Information
  51. 7.9.2 GSK Business Overview
  52. 7.9.3 GSK CGT Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 GSK CGT Drugs Product Portfolio
  54. 7.9.5 GSK Recent Developments
  55. 7.10 Novartis
  56. 7.10.1 Novartis Company Information
  57. 7.10.2 Novartis Business Overview
  58. 7.10.3 Novartis CGT Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Novartis CGT Drugs Product Portfolio
  60. 7.10.5 Novartis Recent Developments
  61. 7.11 SiBiono
  62. 7.11.1 SiBiono Company Information
  63. 7.11.2 SiBiono Business Overview
  64. 7.11.3 SiBiono CGT Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 SiBiono CGT Drugs Product Portfolio
  66. 7.11.5 SiBiono Recent Developments
  67. 7.12 Sunway Biotech
  68. 7.12.1 Sunway Biotech Company Information
  69. 7.12.2 Sunway Biotech Business Overview
  70. 7.12.3 Sunway Biotech CGT Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 Sunway Biotech CGT Drugs Product Portfolio
  72. 7.12.5 Sunway Biotech Recent Developments
  73. 7.13 Janssen Biotech
  74. 7.13.1 Janssen Biotech Company Information
  75. 7.13.2 Janssen Biotech Business Overview
  76. 7.13.3 Janssen Biotech CGT Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 Janssen Biotech CGT Drugs Product Portfolio
  78. 7.13.5 Janssen Biotech Recent Developments
  79. 7.14 Sequoia
  80. 7.14.1 Sequoia Company Information
  81. 7.14.2 Sequoia Business Overview
  82. 7.14.3 Sequoia CGT Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  83. 7.14.4 Sequoia CGT Drugs Product Portfolio
  84. 7.14.5 Sequoia Recent Developments
8 North America
  1. 8.1 North America CGT Drugs Market Size by Type
  2. 8.1.1 North America CGT Drugs Revenue by Type (2021-2032)
  3. 8.1.2 North America CGT Drugs Sales by Type (2021-2032)
  4. 8.1.3 North America CGT Drugs Price by Type (2021-2032)
  5. 8.2 North America CGT Drugs Market Size by Application
  6. 8.2.1 North America CGT Drugs Revenue by Application (2021-2032)
  7. 8.2.2 North America CGT Drugs Sales by Application (2021-2032)
  8. 8.2.3 North America CGT Drugs Price by Application (2021-2032)
  9. 8.3 North America CGT Drugs Market Size by Country
  10. 8.3.1 North America CGT Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America CGT Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America CGT Drugs Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
9 Europe
  1. 9.1 Europe CGT Drugs Market Size by Type
  2. 9.1.1 Europe CGT Drugs Revenue by Type (2021-2032)
  3. 9.1.2 Europe CGT Drugs Sales by Type (2021-2032)
  4. 9.1.3 Europe CGT Drugs Price by Type (2021-2032)
  5. 9.2 Europe CGT Drugs Market Size by Application
  6. 9.2.1 Europe CGT Drugs Revenue by Application (2021-2032)
  7. 9.2.2 Europe CGT Drugs Sales by Application (2021-2032)
  8. 9.2.3 Europe CGT Drugs Price by Application (2021-2032)
  9. 9.3 Europe CGT Drugs Market Size by Country
  10. 9.3.1 Europe CGT Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe CGT Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe CGT Drugs Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Netherlands
10 China
  1. 10.1 China CGT Drugs Market Size by Type
  2. 10.1.1 China CGT Drugs Revenue by Type (2021-2032)
  3. 10.1.2 China CGT Drugs Sales by Type (2021-2032)
  4. 10.1.3 China CGT Drugs Price by Type (2021-2032)
  5. 10.2 China CGT Drugs Market Size by Application
  6. 10.2.1 China CGT Drugs Revenue by Application (2021-2032)
  7. 10.2.2 China CGT Drugs Sales by Application (2021-2032)
  8. 10.2.3 China CGT Drugs Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia CGT Drugs Market Size by Type
  2. 11.1.1 Asia CGT Drugs Revenue by Type (2021-2032)
  3. 11.1.2 Asia CGT Drugs Sales by Type (2021-2032)
  4. 11.1.3 Asia CGT Drugs Price by Type (2021-2032)
  5. 11.2 Asia CGT Drugs Market Size by Application
  6. 11.2.1 Asia CGT Drugs Revenue by Application (2021-2032)
  7. 11.2.2 Asia CGT Drugs Sales by Application (2021-2032)
  8. 11.2.3 Asia CGT Drugs Price by Application (2021-2032)
  9. 11.3 Asia CGT Drugs Market Size by Country
  10. 11.3.1 Asia CGT Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia CGT Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia CGT Drugs Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA CGT Drugs Market Size by Type
  2. 12.1.1 SAMEA CGT Drugs Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA CGT Drugs Sales by Type (2021-2032)
  4. 12.1.3 SAMEA CGT Drugs Price by Type (2021-2032)
  5. 12.2 SAMEA CGT Drugs Market Size by Application
  6. 12.2.1 SAMEA CGT Drugs Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA CGT Drugs Sales by Application (2021-2032)
  8. 12.2.3 SAMEA CGT Drugs Price by Application (2021-2032)
  9. 12.3 SAMEA CGT Drugs Market Size by Country
  10. 12.3.1 SAMEA CGT Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA CGT Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA CGT Drugs Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 CGT Drugs Value Chain Analysis
  2. 13.1.1 CGT Drugs Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 CGT Drugs Production Mode & Process
  6. 13.2 CGT Drugs Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 CGT Drugs Distributors
  9. 13.2.3 CGT Drugs Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst